250 related articles for article (PubMed ID: 27791288)
1. Enhancement of Muramyl Dipeptide-Dependent NOD2 Activity by a Self-Derived Peptide.
Mann JK; Shen J; Park S
J Cell Biochem; 2017 May; 118(5):1227-1238. PubMed ID: 27791288
[TBL] [Abstract][Full Text] [Related]
2. Molecular Recognition of Muramyl Dipeptide Occurs in the Leucine-rich Repeat Domain of Nod2.
Lauro ML; D'Ambrosio EA; Bahnson BJ; Grimes CL
ACS Infect Dis; 2017 Apr; 3(4):264-270. PubMed ID: 27748583
[TBL] [Abstract][Full Text] [Related]
3. Computational studies on receptor-ligand interactions between novel buffalo (Bubalus bubalis) nucleotide-binding oligomerization domain-containing protein 2 (NOD2) variants and muramyl dipeptide (MDP).
Brahma B; Patra MC; Mishra P; De BC; Kumar S; Maharana J; Vats A; Ahlawat S; Datta TK; De S
J Mol Graph Model; 2016 Apr; 65():15-26. PubMed ID: 26897084
[TBL] [Abstract][Full Text] [Related]
4. Species-specific engagement of human nucleotide oligomerization domain 2 (NOD)2 and Toll-like receptor (TLR) signalling upon intracellular bacterial infection: role of Crohn's associated NOD2 gene variants.
Salem M; Seidelin JB; Eickhardt S; Alhede M; Rogler G; Nielsen OH
Clin Exp Immunol; 2015 Mar; 179(3):426-34. PubMed ID: 25335775
[TBL] [Abstract][Full Text] [Related]
5. MDP-Induced selective tolerance to TLR4 ligands: impairment in NOD2 mutant Crohn's disease patients.
Cantó E; Moga E; Ricart E; Garcia-Bosch O; Garcia-Planella E; Juarez C; Vidal S
Inflamm Bowel Dis; 2009 Nov; 15(11):1686-96. PubMed ID: 19572373
[TBL] [Abstract][Full Text] [Related]
6. Pathogen sensing by nucleotide-binding oligomerization domain-containing protein 2 (NOD2) is mediated by direct binding to muramyl dipeptide and ATP.
Mo J; Boyle JP; Howard CB; Monie TP; Davis BK; Duncan JA
J Biol Chem; 2012 Jun; 287(27):23057-67. PubMed ID: 22549783
[TBL] [Abstract][Full Text] [Related]
7. Muramyl dipeptide-induced differential gene expression in NOD2 mutant and wild-type Crohn's disease patient-derived dendritic cells.
Zelinkova Z; van Beelen AJ; de Kort F; Moerland PD; Ver Loren van Themaat E; te Velde AA; van Deventer SJ; de Jong EC; Hommes DW
Inflamm Bowel Dis; 2008 Feb; 14(2):186-94. PubMed ID: 17941075
[TBL] [Abstract][Full Text] [Related]
8. NOD2 engagement induces proinflammatory cytokine production, but not apoptosis, in leukocytes isolated from patients with Crohn's disease.
Bodar E; Netea MG; de Jong DJ; Kullberg BJ; Joosten LA; Van der Meer JW
Eur Cytokine Netw; 2008 Dec; 19(4):185-9. PubMed ID: 19103524
[TBL] [Abstract][Full Text] [Related]
9. Identification of a synthetic muramyl peptide derivative with enhanced Nod2 stimulatory capacity.
Rubino SJ; Magalhaes JG; Philpott D; Bahr GM; Blanot D; Girardin SE
Innate Immun; 2013 Oct; 19(5):493-503. PubMed ID: 23339926
[TBL] [Abstract][Full Text] [Related]
10. Blau syndrome NOD2 mutations result in loss of NOD2 cross-regulatory function.
Mao L; Dhar A; Meng G; Fuss I; Montgomery-Recht K; Yang Z; Xu Q; Kitani A; Strober W
Front Immunol; 2022; 13():988862. PubMed ID: 36189261
[TBL] [Abstract][Full Text] [Related]
11. The effect of NOD2 activation on TLR2-mediated cytokine responses is dependent on activation dose and NOD2 genotype.
Borm ME; van Bodegraven AA; Mulder CJ; Kraal G; Bouma G
Genes Immun; 2008 Apr; 9(3):274-8. PubMed ID: 18340358
[TBL] [Abstract][Full Text] [Related]
12. Crohn's Disease Variants of Nod2 Are Stabilized by the Critical Contact Region of Hsp70.
Schaefer AK; Wastyk HC; Mohanan V; Hou CW; Lauro ML; Melnyk JE; Burch JM; Grimes CL
Biochemistry; 2017 Aug; 56(34):4445-4448. PubMed ID: 28792733
[TBL] [Abstract][Full Text] [Related]
13. Engagement of NOD2 has a dual effect on proIL-1beta mRNA transcription and secretion of bioactive IL-1beta.
Ferwerda G; Kramer M; de Jong D; Piccini A; Joosten LA; Devesaginer I; Girardin SE; Adema GJ; van der Meer JW; Kullberg BJ; Rubartelli A; Netea MG
Eur J Immunol; 2008 Jan; 38(1):184-91. PubMed ID: 18157816
[TBL] [Abstract][Full Text] [Related]
14. Distinct roles for Nod2 protein and autocrine interleukin-1beta in muramyl dipeptide-induced mitogen-activated protein kinase activation and cytokine secretion in human macrophages.
Hedl M; Abraham C
J Biol Chem; 2011 Jul; 286(30):26440-9. PubMed ID: 21659536
[TBL] [Abstract][Full Text] [Related]
15. Nucleotide-binding oligomerization domain containing 2: structure, function, and diseases.
Yao Q
Semin Arthritis Rheum; 2013 Aug; 43(1):125-30. PubMed ID: 23352252
[TBL] [Abstract][Full Text] [Related]
16. Identification of MDP (muramyl dipeptide)-binding key domains in NOD2 (nucleotide-binding and oligomerization domain-2) receptor of Labeo rohita.
Maharana J; Swain B; Sahoo BR; Dikhit MR; Basu M; Mahapatra AS; Jayasankar P; Samanta M
Fish Physiol Biochem; 2013 Aug; 39(4):1007-23. PubMed ID: 23255217
[TBL] [Abstract][Full Text] [Related]
17. Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease.
van Heel DA; Ghosh S; Butler M; Hunt KA; Lundberg AM; Ahmad T; McGovern DP; Onnie C; Negoro K; Goldthorpe S; Foxwell BM; Mathew CG; Forbes A; Jewell DP; Playford RJ
Lancet; 2005 May 21-27; 365(9473):1794-6. PubMed ID: 15910952
[TBL] [Abstract][Full Text] [Related]
18. The molecular chaperone HSP70 binds to and stabilizes NOD2, an important protein involved in Crohn disease.
Mohanan V; Grimes CL
J Biol Chem; 2014 Jul; 289(27):18987-98. PubMed ID: 24790089
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in Crohn's disease by nucleotide oligomerization domain 2-dependent and -independent pathways.
Brosbøl-Ravnborg A; Hvas CL; Agnholt J; Dahlerup JF; Vind I; Till A; Rosenstiel P; Höllsberg P
Clin Exp Immunol; 2009 Mar; 155(3):487-95. PubMed ID: 19094116
[TBL] [Abstract][Full Text] [Related]
20. Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease.
van Heel DA; Ghosh S; Hunt KA; Mathew CG; Forbes A; Jewell DP; Playford RJ
Gut; 2005 Nov; 54(11):1553-7. PubMed ID: 15928043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
